DyNAbind GmbH and CEITEC Masaryk University will work on drug candidates targeting human 14-3-3 protein complexes.
The centre will be closed between 25 June and 17 September to install the new equipment and modernise the whole area.
Software named ScaffOpt predicts the affinity of a candidate ligand and its mode of interaction with the targeted...
It gives scientists the opportunity to receive funding of 230 thousand USD per year for five years.